Literature DB >> 29662275

Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood.

Suvarna Satish Khadilkar1.   

Abstract

Year:  2017        PMID： 29662275      PMCID： PMC5895545          DOI： 10.1007/s13224-017-1029-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  7 in total

1.  Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera.

Authors:  John Jain; Caryn Dutton; Antonia Nicosia; Charlie Wajszczuk; Frederick R Bode; Daniel R Mishell
Journal:  Contraception       Date:  2004-07       Impact factor: 3.375

2.  Three methods of estimating births averted nationally by contraception.

Authors:  Li Liu; Stan Becker; Amy Tsui; Saifuddin Ahmed
Journal:  Popul Stud (Camb)       Date:  2008-07

3.  Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.

Authors:  C Sekadde-Kigondu; E G Mwathe; J K Ruminjo; D Nichols; K Katz; K Jessencky; J Liku
Journal:  East Afr Med J       Date:  1996-12

4.  The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review.

Authors:  P C Schwallie; J R Assenzo
Journal:  Contraception       Date:  1974-08       Impact factor: 3.375

5.  Global trends in use of long-acting reversible and permanent methods of contraception: Seeking a balance.

Authors:  Ritu Joshi; Suvarna Khadilkar; Madhuri Patel
Journal:  Int J Gynaecol Obstet       Date:  2015-10       Impact factor: 3.561

6.  Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.

Authors: 
Journal:  Contraception       Date:  1983-07       Impact factor: 3.375

7.  A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.

Authors:  S Said; K Omar; S Koetsawang; O Kiriwat; Y Srisatayapan; A Kazi; F Ajmal; H H Wynter; A Pretnar-Darovec; I B Benitez
Journal:  Contraception       Date:  1987-06       Impact factor: 3.375
  7 in total
  1 in total

1.  Prevalence and reasons behind use of injectable contraceptive among the women of reproductive age group: A cross-sectional survey in rural areas of Nadia District, West Bengal.

Authors:  Anwesha Bairagya; Gandhari Basu; Reshmi Mondal; Suman Kumar Roy
Journal:  J Family Med Prim Care       Date:  2021-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.